Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.
前日終値
$154.18
+$2.02 · +1.33%
日中の時刻はETです。市場データは遅延する場合があります。
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.
日中レンジ
現在 $154.18
52週レンジ
現在 $154.18
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
65
割安
センチメント
56
まちまち
リスク
34
中程度のリスク
モメンタム
52
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.
日中レンジ
現在 $154.18
52週レンジ
現在 $154.18
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 28.56億 USD | 27.55億 USD | 27.51億 USD | 33.12億 USD | 38.28億 USD |
| 売上原価 | 13.4億 USD | 14.32億 USD | 14.28億 USD | 15.51億 USD | 15.46億 USD |
| 粗利益 | 15.16億 USD | 13.23億 USD | 13.22億 USD | 17.61億 USD | 22.82億 USD |
| 研究開発 | 2.16億 USD | 1.97億 USD | 2.17億 USD | 2.22億 USD | 2億 USD |
| 販売・一般管理 | 9.45億 USD | 7.15億 USD | 7.06億 USD | 7.58億 USD | 7.42億 USD |
| 営業費用 | 11.59億 USD | 9.12億 USD | 9.23億 USD | 9.8億 USD | 9.42億 USD |
| 受取利息 | 3110.3万 USD | 7319万 USD | 7213.1万 USD | 358.9万 USD | 224.1万 USD |
| 支払利息 | 9218.5万 USD | 9627.8万 USD | 9881.3万 USD | 1.04億 USD | 1.02億 USD |
| 減価償却費と償却費 | 4.05億 USD | 4.28億 USD | 4.32億 USD | 4.27億 USD | 3.11億 USD |
| 営業利益 | 3.57億 USD | 4.11億 USD | 3.99億 USD | 7.81億 USD | 13.4億 USD |
| 純利益 | 2.42億 USD | 2.96億 USD | −1.18億 USD | 5.69億 USD | 9.43億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$132.13
下落余地(14.30%)分割調整後の1株当たりの年間現金分配金。
$0.28
2025年(通年)0.0% 以来 2021
2026年(一部):$0.21
$0.28
2,021
$0.28
2,022
$0.28
2,023
$0.28
2,024
$0.28
2,025
$0.21
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当予定 | 2026年10月23日 | $0.07Quarterly | 2026年10月23日 | 2026年11月13日 |
配当 | 2026年7月17日 | $0.07Quarterly | 2026年7月17日 | 2026年8月7日 |
配当 | 2026年4月17日 | $0.07Quarterly | 2026年4月17日 | 2026年5月8日 |
配当 | 2026年1月16日 | $0.07Quarterly | 2026年1月16日 | 2026年2月6日 |
配当 | 2025年10月17日 | $0.07Quarterly | 2025年10月17日 | 2025年11月7日 |
配当 | 2025年7月18日 | $0.07Quarterly | 2025年7月18日 | 2025年8月8日 |
配当落ち 2026年10月23日
$0.07
Quarterly
2026年10月23日基準 · 支払日 2026年11月13日
配当落ち 2026年7月17日
$0.07
Quarterly
2026年7月17日基準 · 支払日 2026年8月7日
配当落ち 2026年4月17日
$0.07
Quarterly
2026年4月17日基準 · 支払日 2026年5月8日
配当落ち 2026年1月16日
$0.07
Quarterly
2026年1月16日基準 · 支払日 2026年2月6日
配当落ち 2025年10月17日
$0.07
Quarterly
2025年10月17日基準 · 支払日 2025年11月7日
配当落ち 2025年7月18日
$0.07
Quarterly
2025年7月18日基準 · 支払日 2025年8月8日
この株式へのエクスポージャーを報告している上場投資信託です。
State Street SPDR S&P 500 ETF1557.T328.95億0.03%129.35兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI4.56億0.02%2.3兆 USD0.03%$381.94+0.63%
Vanguard S&P 500 ETFVOO3.81億0.02%1.8兆 USD0.03%$715.59+0.61%
Vanguard Morningstar Small-Cap ETFVB3.3億0.18%1853億 USD0.03%$289.48+0.64%
iShares Core S&P 500 ETFIVV2.26億0.03%8964.4億 USD0.03%$781.97+0.60%
Vanguard Morningstar Small-Cap Value ETFVBR2.1億0.31%682億 USD0.05%$234.43+0.22%
State Street SPDR S&P 500 ETFSPY2.08億0.03%8172億 USD0.09%$778.57+0.60%
Dimensional - US Targeted Value ETFDFAT1.48億0.49%301.22億 USD0.33%$67.27-0.43%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Small-Cap ETFVB
iShares Core S&P 500 ETFIVV
Vanguard Morningstar Small-Cap Value ETFVBR
State Street SPDR S&P 500 ETFSPY
Dimensional - US Targeted Value ETFDFATAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。